Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0NB
|
|||
Former ID |
DNC011510
|
|||
Drug Name |
2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine
|
|||
Synonyms |
CHEMBL32958; 1H-Indole-5-ethanamine, 2,3-dihydro-alpha-methyl-; 2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine; BDBM50025081
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H16N2
|
|||
Canonical SMILES |
CC(CC1=CC2=C(C=C1)NCC2)N
|
|||
InChI |
1S/C11H16N2/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-3,7-8,13H,4-6,12H2,1H3
|
|||
InChIKey |
YAVKNEHUAXPRSK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
Norepinephrine transporter (NET) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-... J Med Chem. 1986 Aug;29(8):1406-12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.